News Room

Follow:
6407 Articles
Leadership 6 Min Read

Execs Think They Develop Strong Leaders—68% Of Gen Z Disagrees

A recent study by GE showed that while 90 percent of C-suite executives say their company supports the development of

Startups 7 Min Read

Houston, We Have A Massive Healthcare Cost Problem

Paul Markovich - President and CEO, Blue Shield of California. After decades of failed attempts and political contempt that’s kept

Leadership 10 Min Read

15 Agency Pros Share Interesting Client Challenges And Lessons Learned

If there is one truth marketers, advertisers and public relations professionals can all attest to, it’s that life in the

Marketing 3 Min Read

Social media trends: Creators, both fake and real

Each week, Marketing Brew recaps what people are talking about on social media, the trends that took over our feeds,

Startups 8 Min Read

A Gateway To Entrepreneurial Success

Founding CEO of LoginRadius, a startup enthusiast and a board member. Helping enterprises secure billions of digital identities worldwide. As

Leadership 5 Min Read

Major University Endowments Are Posting Mixed Returns For FY 2023

Several major universities and colleges have posted their endowment returns for the 2023 fiscal year, and the initial pattern has

Marketing 7 Min Read

Brands can’t get enough of pickleball

Pickleball, a sport originally associated with an older crowd, is now a favorite pastime among players of all ages. It’s

Startups 8 Min Read

6 ChatGPT Prompts To Make Your Best Ever Hire

Recruitment is inherently biased. When you sit opposite someone in an interview, whether in-person or virtual, you’re falling for so

Leadership 7 Min Read

Why Leaders Are Often The Last To Know And What You Can Do About It

Leadership myopia is real, and your managers most likely suffer from it. Although positions of power and fancy corner offices

Startups 8 Min Read

Business Lessons From Taylor Swift

Pelin Thorogood is the Executive Chair of Radicle Science, Proof-as-a-Service pioneer of supplements' first easy path to clinical trials. Whether